Beyond Air, Inc. is a healthcare company based in the United States that specializes in developing a cutting-edge Nitric Oxide (NO) Generator and Delivery System for the treatment of respiratory and other diseases. With a solid ESG score of 26.6, Beyond Air is considered a medium risk investment. The company focuses on using NO generated from ambient air to deliver precise amounts to the lungs, potentially revolutionizing treatments for pulmonary hypertension and lower respiratory tract infections.